PFAS at a crossroads: competitiveness, health and the limits of one-size-fits-all regulation to manage “forever chemicals” in the EU

Per- and polyfluoroalkyl substances (PFAS), often referred to as ‘forever chemicals’ for their extreme persistence, have become a defining test of Europe’s ability to reconcile environmental ambition with industrial competitiveness. The discussion increasingly centres on how to balance environmental and health objectives with economic resilience and long-term competitiveness. Consideration of the costs associated with continued PFAS use sits alongside growing awareness of the economic, health and environmental consequences of inaction.

The PFAS group encompasses a wide range of sub‑families with very different properties, uses and risk profiles. Discussion on this heterogeneity sits at the core of the EU-level policy debate, as it complicates the development of proportionate regulatory measures.

At the same time, there is broad recognition that PFAS remain essential to strategic value chains and underpin several critical applications across sectors central to Europe’s green and industrial transition.

The rapid pace and expanding scope of regulatory initiatives are creating both significant compliance challenges and strategic opportunities, especially for industries where PFAS performance on durability and resistance remains unmatched and provides long-term investment predictability. Since the proposed restriction on PFAS under the REACH Regulation, first put forward in 2023 and covering more than 10.000 different substances, the past months have seen considerable ferment, with further developments expected in the coming months.

What’s on the table: the EU’s “universal restriction” proposal

In 2023, Sweden, Denmark, Germany, Norway, and the Netherlands submitted a proposal for a “universal restriction” on all PFAS-containing products. If adopted, it would mark an unprecedented shift from substance-by-substance regulation to a class-based precautionary approach, allowing time-limited derogations where uses are deemed essential and no safer alternatives exist.

While the proposal covers more than 10.000 different substances, PFAS encompass a wide range of subfamilies with very different properties, uses, and risk profiles, and the available data on environmental fate and health effects remains uneven across this spectrum. In particular, fluoropolymers are often highlighted as an area where exposure pathways and long-term impacts are less well characterised, making it challenging to draw clear, across-the-board conclusions. This lack of a comprehensive, comparable picture across all PFAS subgroups continues to complicate efforts to design proportionate and scientifically robust regulation.

Since entering the regulatory process, the proposal has triggered intense debate. The focus has moved beyond whether PFAS should be regulated to how fast, how broadly, and at what cost.

Competitiveness takes centre stage

In December last year, the European Parliament’s ITRE Committee commissioned a report on “The PFAS and their role as enablers in the competitiveness of European industry”. The study combines an Assessment of Alternatives (AoA) with a Socio-Economic Analysis (SEA) to examine the potential impacts of a broad PFAS restriction. Focusing on six key fluoropolymers across four strategic sectors (aerospace, defence, green energy/clean tech, and semiconductors), it concludes that a one-size-fits-all approach may not adequately reflect the very different technical and economic realities across applications.

The report warns that the availability and feasibility of alternatives vary significantly by use, and that an EU-wide PFAS restriction risks becoming one of the most stringent regimes globally, with the potential to cause major disruptions where substitutes are not yet viable. At the same time, the proposal is raising broader questions about industrial competitiveness. A particular distinction in the debate is made between applications with direct consumer exposure, such as packaging or cosmetics, and those where PFAS are used within industrial components and limited direct consumer exposure, including batteries, semiconductors and renewable energy technologies. In some of these uses, alternatives exist but may not yet meet the required technical performance, raising questions about substitution timelines. For the industry, this also links to the need for regulatory predictability, particularly for long-term investments.

The impacts of a universal ban would therefore translate into significant transition costs for industrial activity, including employment and SMEs.

The study, therefore, supports a more differentiated, sector-specific approach. It calls for targeted restrictions combined with derogations where PFAS remain essential, alongside strict emission controls, end-of-life obligations and remediation measures. For sectors such as aerospace, defence and semiconductors, where substitution is particularly difficult and qualification cycles are long, it recommends time-unlimited derogations subject to regular review. For green and clean-tech uses, it favours case-by-case assessments and argues that F-gases should continue to be regulated under the existing F-gas framework.

The costs of contamination

This February, the authors of the abovementioned study engaged in a meaningful conversation with ITRE MEPs from the Greens/EFA, Renew and EPP, who raised questions and concerns regarding the scope, methodology and conclusions of the study, highlighting the already substantial and growing economic burden of PFAS pollution. From water treatment and environmental remediation to healthcare impacts, these costs are no longer theoretical.

Beyond regulatory design, the economic cost of inaction is also coming into focus. A Commission-backed study published by DG Environment in January 2026 aligns with this view and estimates that PFAS-related remediation and societal costs could reach between €330 billion and €1.7 trillion by 2050, depending on policy choices. It shows how the persistence and mobility of PFAS drive long-term costs, with substances such as trifluoroacetic acid (TFA) now widespread in European water bodies. Drinking water treatment alone to address TFA could cost €14–15 billion annually.

The debate is far from settled

The evolving policy debate has also drawn significant attention from environmental and health NGOs, who strongly criticise the framing of “competitiveness” and warn that it risks justifying delays to meaningful action on “forever chemicals”. Groups such as ChemSec argue that competitiveness-focused assessments overstate economic risks by relying on narrow analyses of a limited subset of PFAS, while underestimating the availability of safer alternatives and the innovation-driving effect of clear, class-based regulation.

The European Environmental Bureau (EEB) has echoed these concerns, cautioning that competitiveness rhetoric is increasingly being used as a cover for “pollute as usual”. In its view, this approach shifts the health, environmental and cleanup costs of PFAS contamination away from industry and onto citizens and public authorities.

At the same time, more than 100 civil society organisations have endorsed the STOP PFAS Manifesto, calling for a universal PFAS restriction with only time-limited derogations for essential uses, and for application of the polluter pays principle to address legacy contamination.

What happens next

On 11 March 2026, the European Chemicals Agency (ECHA)’s Committee for Socio-Economic Analysis (SEAC) agreed its draft opinion on a proposal to restrict the manufacture, placing on the market and use of PFAS in the EU, following an extensive and independent assessment of the socio‑economic impacts of a potential restriction as well as an analysis of available alternatives. As a next step, ECHA is expected to open a consultation on this draft opinion in April 2026.

As discussions remain ongoing, what is clear is that the coming months will be decisive. The PFAS file has become a litmus test for the EU’s ability to reconcile industrial policy, environmental ambition and public trust, not only by choosing the right level of regulatory ambition, but also by demonstrating that a class-based approach can accommodate scientific nuance without losing credibility. How policymakers navigate these tradeoffs will shape Europe’s chemicals landscape for decades to come.